Search - tctmd.com

Displaying 81 - 100 of 162

Sort: Relevancy | Date

Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity

Michael O'Riordan

May 16, 2025

News Conference News European Congress on Obesity 2025

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

Michael O'Riordan

May 14, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Conference News European Congress on Obesity 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Conference News EAS 2025

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Yael L. Maxwell

May 08, 2025

Podcast Heart Valve Matters

The EARLY TAVR Trial: A Clinical Cardiologist’s Perspective

May 08, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

HDL Cholesterol Levels May Sway Statin Decisions in Primary Prevention

Michael O'Riordan

May 02, 2025

News Daily News

Donor Hearts Fare Better With Novel Method After Circulatory Death

Michael O'Riordan

May 01, 2025

News Daily News

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Michael O'Riordan

May 01, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

News Daily News

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Yael L. Maxwell

April 24, 2025

News Daily News

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Caitlin E. Cox

April 23, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

Podcast TCTMD Talking Points

The EARTH-STEMI Trial

April 16, 2025

News Daily News

Weekend Warriors Also See Mortality Benefits With Exercise

Michael O'Riordan

April 10, 2025

News Daily News

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Michael O'Riordan

April 09, 2025

Podcast TCTMD Talking Points

The SCOFF Trial

April 09, 2025

Advertisement

Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

The EARLY TAVR Trial: A Clinical Cardiologist’s Perspective

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

HDL Cholesterol Levels May Sway Statin Decisions in Primary Prevention

Donor Hearts Fare Better With Novel Method After Circulatory Death

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

The EARTH-STEMI Trial

Weekend Warriors Also See Mortality Benefits With Exercise

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

The SCOFF Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content